Shamburg News · 8-K filed Nov 17, 2026, 4:05 PM EST

Impact Biomedical Stockholders Approve Merger Agreement With Zoar and Elect Eight Directors

IBO · IMPACT BIOMEDICAL INC.

  • Shareholder vote
  • Acquisition
  • Leadership change
  • Materiality: medium

On November 13, 2026, Impact Biomedical Inc. held a special meeting of stockholders at which 7,715,210 shares, or 89.29% of 8,640,000 shares outstanding and eligible to vote, were represented. Stockholders approved the Merger and Share Exchange Agreement with Zoar Limited, Dr Ashleys Nevada Sub, Inc., Zoar Labs Limited and the sole Zoar shareholder, as amended, and approved the Amended and Restated Memorandum and Articles of Association. Stockholders also elected eight directors, ratified Grassi & Co. Certified Public Accountants, P.C. as independent auditor for fiscal 2026, approved named executive officer compensation on an advisory basis, and approved adjournment, which was not needed.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 5.07, accession 0001493152-26-052822.

Written from the filing by Shamburg Markets. Figures are as reported by the company.